Subcutaneous administration achieves 7085% bioavailability compared to 4050% for oral routes due to hepatic first-pass metabolism
Factors such as solubility, bioavailability, biological half-life, route of administration, product shelf life, as well as other pharmacological considerations are contemplated herein
Co-administration of PAXLOVID with drugs highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated [see Contraindications (4) and Drug Interactions (7.3) Table 2]
Verified Cleansing System
Research Data Data above is summarised from preclinical and in-vitro literature and is provided for research orientation only
These cells deliver essential oxygen to working muscles during exercise, delaying fatigue and enabling longer training sessions or competitive performances